1）Interleukin-1α inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes.
He J., Usui I., Ishizuka K., Kanatani Y., Hiratani K., Iwata M., Bukhari A., Haruta T., Sasaoka T., Kobayashi M.
Mol Endocrinol, 20:114-124, 2006.

2）Altered subcellular distribution of estrogen receptor α is implicated in estradiol-induced dual regulation of insulin signaling in 3T3-L1 adipocytes.
Nagira K., Saito S., Wada T., Fukui K., Ikubo M., Hori S., Tsuneki H., Kobayashi M., Sasaoka T.
Endocrinology, 147:1020-1028, 2006.

3）Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity.
Sasaoka T., Wada T., Tsuneki H.
Pharmacology and Therapeutics, 112:799-809, 2006.